Vagifem Low Dose for Postmenopausal Atrophic Vaginitis Symptoms
Public ClinicalTrials.gov record NCT00108849. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 12 Month Double-blind, Randomized, Parallel-group, Placebo-controlled, Multi-center Trial to Investigate the Efficacy and Safety of Vagifem Low Dose (10 mcg 17beta-estradiol Vaginal Tablet) for the Treatment of Postmenopausal Atrophic Vaginitis Symptoms
Study identification
- NCT ID
- NCT00108849
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Novo Nordisk A/S
- Industry
- Enrollment
- 309 participants
Conditions and interventions
Conditions
Interventions
- estradiol, 10 mcg Drug
Drug
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 28, 2005
- Primary completion
- Apr 30, 2007
- Completion
- Apr 30, 2007
- Last update posted
- Feb 7, 2017
2005 – 2007
United States locations
- U.S. sites
- 51
- U.S. states
- 26
- U.S. cities
- 48
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Novo Nordisk Investigational Site | Mobile | Alabama | 36608 | — |
| Novo Nordisk Investigational Site | Montgomery | Alabama | 36106 | — |
| Novo Nordisk Investigational Site | Phoenix | Arizona | 85050 | — |
| Novo Nordisk Investigational Site | Tucson | Arizona | 85712 | — |
| Novo Nordisk Investigational Site | Carmichael | California | 95608 | — |
| Novo Nordisk Investigational Site | Palo Alto | California | 94304 | — |
| Novo Nordisk Investigational Site | San Diego | California | 92108 | — |
| Novo Nordisk Investigational Site | San Diego | California | 92123 | — |
| Novo Nordisk Investigational Site | Denver | Colorado | 80218 | — |
| Novo Nordisk Investigational Site | Denver | Colorado | 80220 | — |
| Novo Nordisk Investigational Site | Lakewood | Colorado | 80228 | — |
| Novo Nordisk Investigational Site | New London | Connecticut | 06320 | — |
| Novo Nordisk Investigational Site | Clearwater | Florida | 33759 | — |
| Novo Nordisk Investigational Site | Daytona Beach | Florida | 32114 | — |
| Novo Nordisk Investigational Site | Palm Springs | Florida | 33461 | — |
| Novo Nordisk Investigational Site | Plantation | Florida | 33324 | — |
| Novo Nordisk Investigational Site | Tampa | Florida | 33607 | — |
| Novo Nordisk Investigational Site | West Palm Beach | Florida | 33409 | — |
| Novo Nordisk Investigational Site | Alpharetta | Georgia | 30005 | — |
| Novo Nordisk Investigational Site | Roswell | Georgia | 30075 | — |
| Novo Nordisk Investigational Site | Boise | Idaho | 83702 | — |
| Novo Nordisk Investigational Site | Peoria | Illinois | 61615 | — |
| Novo Nordisk Investigational Site | Evansville | Indiana | 47714 | — |
| Novo Nordisk Investigational Site | Lexington | Kentucky | 40536-0293 | — |
| Novo Nordisk Investigational Site | Laurel | Maryland | 20707 | — |
| Novo Nordisk Investigational Site | Lincoln | Nebraska | 68510 | — |
| Novo Nordisk Investigational Site | Lawrenceville | New Jersey | 08648 | — |
| Novo Nordisk Investigational Site | Moorestown | New Jersey | 08057 | — |
| Novo Nordisk Investigational Site | New York | New York | 10016 | — |
| Novo Nordisk Investigational Site | Charlotte | North Carolina | 28209 | — |
| Novo Nordisk Investigational Site | Mount Airy | North Carolina | 27030 | — |
| Novo Nordisk Investigational Site | Winston-Salem | North Carolina | 27103 | — |
| Novo Nordisk Investigational Site | Cleveland | Ohio | 44122 | — |
| Novo Nordisk Investigational Site | Columbus | Ohio | 43210 | — |
| Novo Nordisk Investigational Site | Eugene | Oregon | 97401 | — |
| Novo Nordisk Investigational Site | Medford | Oregon | 97504 | — |
| Novo Nordisk Investigational Site | Philadelphia | Pennsylvania | 19114 | — |
| Novo Nordisk Investigational Site | Pittsburgh | Pennsylvania | 15206 | — |
| Novo Nordisk Investigational Site | West Reading | Pennsylvania | 19611 | — |
| Novo Nordisk Investigational Site | Charleston | South Carolina | 29401 | — |
| Novo Nordisk Investigational Site | Columbia | South Carolina | 29201 | — |
| Novo Nordisk Investigational Site | Greenville | South Carolina | 29607 | — |
| Novo Nordisk Investigational Site | Jackson | Tennessee | 38305 | — |
| Novo Nordisk Investigational Site | Memphis | Tennessee | 38120 | — |
| Novo Nordisk Investigational Site | Houston | Texas | 77030 | — |
| Novo Nordisk Investigational Site | Sandy City | Utah | 84070 | — |
| Novo Nordisk Investigational Site | Norfolk | Virginia | 23507 | — |
| Novo Nordisk Investigational Site | Spokane | Washington | 99204 | — |
| Novo Nordisk Investigational Site | Spokane | Washington | 99207 | — |
| Novo Nordisk Investigational Site | Tacoma | Washington | 98405 | — |
| Novo Nordisk Investigational Site | Milwaukee | Wisconsin | 53209 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00108849, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 7, 2017 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00108849 live on ClinicalTrials.gov.